FSI
HZNP

Flow State Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Flow State Investments’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-119,935
Closed -$13.9M – 280
2023
Q3 		$13.9M Buy
119,935
+56,535
+89% +$6.07M 4.3% 3
2023
Q2 		$6.52M Buy
63,400
+14,400
+29% +$1.52M 2.5% 12
2023
Q1 		$5.35M Buy
49,000
+29,000
+145% +$3.21M 4.34% 4
2022
Q4 		$2.28M Buy
+20,000
New +$1.66M 1.98% 18

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Flow State Investments's HZNP Position: Q4 2023 in Review

Flow State Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 119,935 shares — an estimated $13.9M sold.

Flow State Investments first reported a position in HZNP in Q4 2022 and held it in 4 quarters. The position peaked at $13.9M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Flow State Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Flow State Investments sold 119,935 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $13.9M.
  • Flow State Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022 and held it in 4 quarters.
  • Flow State Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $13.9M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Flow State Investments's 13F filing for Q4 2023, filed 14 Feb 2024.